.FDA declines experimental MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Declines to Authorize MDMA Therapy, Looking For Even More Research The New York City TimesFDA Denies Ecstasy-Based Medication The Stock market JournalFDA declines to authorize unfamiliar MDMA treatment to deal with post-traumatic stress disorder, with ask for even more trial records CNNFDA denies to begin with psychedelic to deal with post-traumatic stress disorder, asking for additional research The Washington Blog post.